219 related articles for article (PubMed ID: 35268449)
1. Systemic Juvenile Idiopathic Arthritis/Pediatric Still's Disease, a Syndrome but Several Clinical Forms: Recent Therapeutic Approaches.
Quartier P
J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268449
[TBL] [Abstract][Full Text] [Related]
2. Diagnosing and Treating Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease as Part of the Still's Disease Continuum.
Kontzias A; Petryna O; Nakasato P; Efthimiou P
Mediterr J Rheumatol; 2024 Mar; 35(Suppl 1):45-57. PubMed ID: 38756937
[TBL] [Abstract][Full Text] [Related]
3. Case report: Emapalumab for active disease control prior to hematopoietic stem cell transplantation in refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
Chellapandian D; Milojevic D
Front Pediatr; 2023; 11():1123104. PubMed ID: 36891226
[TBL] [Abstract][Full Text] [Related]
4. Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity.
Nirmala N; Brachat A; Feist E; Blank N; Specker C; Witt M; Zernicke J; Martini A; Junge G
Pediatr Rheumatol Online J; 2015 Nov; 13():50. PubMed ID: 26589963
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still's disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity.
Kudela H; Drynda S; Lux A; Horneff G; Kekow J
BMC Rheumatol; 2019; 3():4. PubMed ID: 30886992
[TBL] [Abstract][Full Text] [Related]
6. Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
Morelle G; Castelle M; Pinto G; Breton S; Bendavid M; Boussard C; Mouy R; Bader-Meunier B; Semeraro M; Faye A; Cavazzana M; Neven B; Blanche S; Quartier P; Moshous D
Pediatr Rheumatol Online J; 2021 Mar; 19(1):27. PubMed ID: 33712044
[TBL] [Abstract][Full Text] [Related]
7. Case report: Success of allogeneic hematopoietic stem cell transplantation for refractory systemic-onset juvenile idiopathic arthritis.
Beaufils C; Proulx C; Blincoe A; Teira P; Bittencourt H; Cellot S; Duval M; Morin MP; De Bruycker JJ; Couture J; Samaan K; Decaluwe H; Kleiber N; El-Jalbout R; Touzot F; Haddad E; Barsalou J
Front Med (Lausanne); 2023; 10():1275927. PubMed ID: 37908851
[TBL] [Abstract][Full Text] [Related]
8. Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.
Colafrancesco S; Manara M; Bortoluzzi A; Serban T; Bianchi G; Cantarini L; Ciccia F; Dagna L; Govoni M; Montecucco C; Priori R; Ravelli A; Sfriso P; Sinigaglia L;
Arthritis Res Ther; 2019 Dec; 21(1):275. PubMed ID: 31829244
[TBL] [Abstract][Full Text] [Related]
9. The Role of Interleukin 18/Interleukin 18-Binding Protein in Adult-Onset Still's Disease and Systemic Juvenile Idiopathic Arthritis.
Girard-Guyonvarc'h C; Harel M; Gabay C
J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054124
[TBL] [Abstract][Full Text] [Related]
10. Similar Clinical Outcomes in Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease Treated with Canakinumab: Bayesian and Population Model-Based Analyses.
Dunger-Baldauf C; Nakasato P; Noviello S; Whelan S; Bieth B
Rheumatol Ther; 2022 Apr; 9(2):753-762. PubMed ID: 35044647
[TBL] [Abstract][Full Text] [Related]
11. Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives.
Ambler WG; Nanda K; Onel KB; Shenoi S
Ann Med; 2022 Dec; 54(1):1839-1850. PubMed ID: 35786149
[TBL] [Abstract][Full Text] [Related]
12. Application of systems biology-based in silico tools to optimize treatment strategy identification in Still's disease.
Segú-Vergés C; Coma M; Kessel C; Smeets S; Foell D; Aldea A
Arthritis Res Ther; 2021 Apr; 23(1):126. PubMed ID: 33892792
[TBL] [Abstract][Full Text] [Related]
13. Reasons for Initiating Canakinumab among Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease in the U.S. Real-World Settings.
Hur P; Yi E; Ionescu-Ittu R; Manceur AM; Lomax KG; Cammarota J; Xie J; Gautam R; Nakasato P; Sanghera N; Kim N; Grom AA
Rheumatol Ther; 2022 Feb; 9(1):265-283. PubMed ID: 34874547
[TBL] [Abstract][Full Text] [Related]
14. [Still's disease as biphasic disorder : Current knowledge on pathogenesis and novel treatment approaches].
Föll D; Wittkowski H; Hinze C
Z Rheumatol; 2020 Sep; 79(7):639-648. PubMed ID: 32253510
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups.
Feist E; Quartier P; Fautrel B; Schneider R; Sfriso P; Efthimiou P; Cantarini L; Lheritier K; Leon K; Karyekar CS; Speziale A
Clin Exp Rheumatol; 2018; 36(4):668-675. PubMed ID: 29533755
[TBL] [Abstract][Full Text] [Related]
16. Systemic juvenile idiopathic arthritis versus adult-onset Still´s disease: the pertinence of changing the current classification criteria.
Silva JR; Brito I
Acta Reumatol Port; 2020; 45(2):150-151. PubMed ID: 32895357
[TBL] [Abstract][Full Text] [Related]
17. [Still's disease in children and adults].
Hedrich CM; Günther C; Aringer M
Z Rheumatol; 2017 Sep; 76(7):595-608. PubMed ID: 28755070
[TBL] [Abstract][Full Text] [Related]
18. Treatment of systemic juvenile idiopathic arthritis.
Hinze CH; Foell D; Kessel C
Nat Rev Rheumatol; 2023 Dec; 19(12):778-789. PubMed ID: 37923864
[TBL] [Abstract][Full Text] [Related]
19. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?
Tada Y; Inokuchi S; Maruyama A; Suematsu R; Sakai M; Sadanaga Y; Ono N; Arinobu Y; Koarada S
Rheumatol Int; 2019 Jan; 39(1):97-104. PubMed ID: 30051293
[TBL] [Abstract][Full Text] [Related]
20. Impact of systemic juvenile idiopathic arthritis/Still's disease on adolescents as evidenced through social media posts.
Modica RF; Lomax KG; Batzel P; Cassanas A
Open Access Rheumatol; 2018; 10():73-81. PubMed ID: 29942167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
